Anti-PD-L1 Antibody-Cytokine Fusion Protein, IgG (B50-6)-IFNA2 (CAT#: ACFP-CQ2327)

This antibody-cytokine fusion protein was achieved by conjugating/fusing the Anti-PD-L1 IgG to IFNA2. It was expressed in CHO and purified with affinity chromatography. The immunocytokine retains the ability to bind the PD-L1 as well as the biological activity of IFNA2.


Specific Inquiry
  • Size:
  • Conjugation:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location and Protein Expression
Normal Tissue
RNA Expression

Specifications

  • Target
  • PD-L1
  • Molecule Class
  • IgG-IFNA2
  • Species Reactivity
  • Human
  • Expression Host
  • CHO
  • Clone
  • B50-6
  • Cytokine 1
  • IFNA2
  • Cytokines 1 Description
  • This gene is a member of the alpha interferon gene cluster on chromosome 9. The encoded protein is a cytokine produced in response to viral infection. Use of the recombinant form of this protein has been shown to be effective in reducing the symptoms and duration of the common cold.
  • Cytokine 1 Species
  • Human
  • Applications
  • This product can be used therapeutically to deliver biologically active ligands to a desired tissue.

Target

  • Introduction
  • This gene encodes an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. The encoded protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation.
  • Alternative Names
  • CD274; PD-L1; PDCD1L1; B7-H; Programmed Death Ligand 1; Programmed Cell Death 1 Ligand 1; PDCD1LG1; B7H1

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone B50-6"

See other products for "Cd274"

Chimeric Antibody

Neutralizing Antibody

CAT Product Name Application Type
NEUT-324CQ Mouse Anti-CD274 Recombinant Antibody (clone 29E.2A3.C6) IHC-P, FC, Neut, ICC Mouse IgG2b, κ
NEUT-325CQ Human Anti-CD274 Recombinant Antibody (clone CBLS-206) Neut Human IgG1, κ
NEUT-326CQ Human Anti-CD274 Recombinant Antibody (clone CBLS-207) ELISA, Neut Human IgG1, κ
NEUT-327CQ Mouse Anti-CD274 Recombinant Antibody (clone MIH1) FC, FuncS, Neut, IHC, IF Mouse IgG1, κ
NEUT-330CQ Rat Anti-CD274 Recombinant Antibody (clone MIH5) FC, FuncS, Neut, IHC-Fr, WB Rat IgG2a, λ

ADCC Enhanced Antibody

CAT Product Name Application Type
AFC-TAB-417CQ Afuco™ Anti-CD274 ADCC Recombinant Antibody (Durvalumab), ADCC Enhanced ELISA, IHC, FC, IP, IF, Inhib ADCC enhanced antibody
AFC-TAB-418CQ Afuco™ Anti-CD274 ADCC Recombinant Antibody (Atezolizumab), ADCC Enhanced ELISA, IHC, FC, IP, IF, BL ADCC enhanced antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for ACFP-CQ2327. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare